Case Study Successful Global Site Engagement Solution Customized site engagement solution designed to meet the unique needs of a global pharmaceutical company. Read Now Case Study Assisting a Large Global Sponsor for Oncology Studies Catalyst Flex helped a global pharmaceutical company with resources for its large portfolio of studies. Catalyst Flex quickly stepped in to provide a team of talented individuals with the functional expertise required to deliver our client’s projects. Read Now Info Sheet Developing Cutting-edge Treatments for Ovarian Cancer The second most common gynecological cancer in the world is ovarian cancer. Often diagnosed at Read Now Case Study Oversight Monitoring Successes  A biopharmaceutical company engaged Catalyst Flex to provide appropriate and impartial oversight monitoring for several studies. Such services can help to prevent a sponsor from receiving findings during U.S. Food and Drug Administration (FDA) audits and in particular any Form FDA 483.  Read Now Info Sheet Early-Phase Oncology Research Expertise Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now Case Study Comprehensive and Flexible Partnership to Support Rescue Study  A biotech company new to clinical research with an asset early in its development lifecycle became a long-term partner with Catalyst Flex. For years, Catalyst has worked alongside to help achieve the client’s goals for a single asset for the first bladder cancer therapy on the horizon in the past 20 years. Read Now Case Study Focused Monitoring Support for Rare Disease Study A small biotech needed functional support for a Phase III rare disease study. Although a contract existed between the biotech and a clinical research organization (CRO), the study timelines and budget had slipped. The biotech hired Catalyst Flex to reverse that trend and ultimately saved ~$1 million. Read Now Info Sheet Helping to Bring Cancer Therapies to Patients  Niche CRO with a difference Catalyst Oncology is a niche oncology CRO devoting time, energy, Read Now Article Expanding Clinical Trial Diversity: A Catalyst Values Approach “Today, overall cancer clinical trial enrollment in the United States is 8% (6.3%‐7.0% at community Read Now Info Sheet Helping to Bring Immunotherapies to Cancer Patients in Need Catalyst Oncology is a specialty oncology clinical research organization (CRO) devoting time, energy, and capital Read Now